Falk Gastro Info 2/2023

Video course abdominal ultrasound

Examination of the pancreas: Ductus Wirsungianus

Author: Prof. Dr. Christoph F. Dietrich
©Falk Foundation e.V., Freiburg. All rights reserved.

Please switch on your loudspeakers!
Link to Falk Mediacenter
Latest research in brief:
Image
Colon to Rectum
Text:

Vermeire S et al, Lancet Gastroenterol Hepatol. 2022;7(11):1024–35

 

ABX464 (Obefazimod) for moderate-to-severe active ulcerative colitis: In this phase 2b trial, all doses of ABX464 improved disease activity after 8 weeks significantly better than placebo.

Link to Falk Mediacenter
Text:

Kårhus ML et al, Lancet Gastroenterol Hepatol. 2022;7(10):922–31

 

Liraglutid versus colesevelam for the treatment of bile acid diarrhea: In this pilot trial involving 52 patients, the glucagon-like peptide 1 receptor agonist liraglutide was superior to colesevelam in reducing stool frequency. Larger confirmatory trials powered for superiority are therefore warranted to establish liraglutide as novel treatment alternative.

Link to Falk Mediacenter

El-Salhy M et al, Gastroenterology. 2022;163(4):982–94.e14


 

Efficacy of fecal microbiota transfer (FMT) for patients with irritable bowel syndrome: Results of a randomized trial of FMT after 2 and 3 years indicate that FMT results in high response rates and long-standing effects on dysbiosis with only few and mild self-limited adverse events.

Link to Falk Mediacenter
Image
Liver and Bile Ducts
Text:

Mantovani A et al, Gut 2023;72(2):372–80

 

 

Non-alcoholic fatty liver disease (NAFLD) and risk of new-onset heart failure: A recent meta-analysis shows that patients with NAFLD have a 1.5-fold higher long-term risk of new-onset heart failure, independent of diabetes, hypertension and other common cardiovascular risk factors.

Link to Falk Mediacenter
Text:

Baiges A et al, J Hepatol. 2023;78(1):114–22

 

 

Recurrent thrombosis in people with non-cirrhotic splanchnic vein thrombosis: A current multicenter, retrospective observational study shows a significant risk of splanchnic and/or extrasplanchnic recurrent thrombosis in people with non-cirrhotic splanchnic vein thrombosis of idiopathic or local factor etiology. Splanchnic recurrent thrombosis can be asymptomatic and requires screening for its detection. Values of factor VIII ≥ 150% may help identify individuals at high risk of recurrent thrombosis who could benefit from long-term anticoagulation.

Link to Falk Mediacenter
Text:
Vitale A et al, Gut. 2023;72(1):141–52

Hepatocellular carcinoma (HCC) in metabolic dysfunction-associated fatty liver disease (MAFLD): A recent Italian study shows that MAFLD alone or together with other etiologies is already responsible for > 70% of HCC cases. Despite a less favorable cancer stage at diagnosis, patients with MAFLD-associated HCC have a lower risk of HCC-related death, suggesting reduced cancer aggressiveness.

Link to Falk Mediacenter
Image
Esophagus to Small Intestine
Text:

van Wanrooij RLJ et al, Endoscopy. 2022;54(11):1023–31

 

Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) versus duodenal stenting for malignant gastric outlet obstruction: EUS-GE had higher clinical success and lower stent dysfunction, with similar safety, compared with duodenal stenting, in a multicenter retrospective cohort study using propensity score-matching.

Link to Falk Mediacenter
Text:

Kuipers T et al, Lancet Gastroenterol Hepatol. 2022;7(12):1103–11

 

Peroral endoscopic myotomy (POEM) versus pneumatic dilatation for treatment-naive patients with achalasia: Long-term results after 5 years of a randomized trial indicate that POEM has greater long-term efficacy with a low risk of major treatment-related complications compared to dilatation therapy.

Link to Falk Mediacenter
Image
Pancreas
Text:

Mukherjee S et al, Gastroenterology. 2022;163(5):1435–46.e3

 

Radiomics-based machine-learning models allows earlier diagnosis of pancreactic cancer: Radiomics-based machine learning models can detect pancreatic ductal adenocarcinoma (PDAC) from normal pancreas with a substantial lead time before clinical diagnosis. Prospective validation and integration of such models with complementary biomarkers has the potential for PDAC detection at a stage when surgical cure is still an option.

Link to Falk Mediacenter

Symposium 232

Inflammation of the Upper and Lower GI Tract: Common mechanisms and Treatments or Important Differences?

April 28 – 29, 2023, Bordeaux, France

Program
Online registration

Current Falk literature:

No literature.